Significant Modulations of Linc001128 and Linc0938 With Mir-24-3P and Mir-30C-5P in Parkinson Disease Publisher Pubmed

Summary: Could new lncRNAs help diagnose Parkinson’s? Researchers found two dysregulated networks in PBMCs, highlighting biomarker potential. #ParkinsonsDisease #Genomics

Yousefi M¹ ; Peymani M^{2, 3} ; Ghaedi K⁴ ; Irani S¹ ; Etemadifar M⁵
Source: Scientific Reports Published:2022

Abstract

Parkinson disease (PD) is the second most common neurodegenerative disease; the evidence suggests that lncRNAs and miRNAs play an important role in regulating the PD-related genes. The purpose of this research was to introduce two novel lncRNAs as the biomarker of PD diagnosis and treatment. We evaluated the expression profiles of six nodes of two regulatory networks in the PBMCs which had been got from 38 PD patients and 20 healthy individuals by qRT-PCR. Then, we compared the expression of these RNAs in both early and late stages of PD with the controls to determine if their expression could be related to the severity of disease. Further, this study investigated the direct interaction between one of the lncRNAs and target miRNA by using the dual luciferase assay. The results of the expression profiles of six nodes of the two ceRNA networks shown that linc01128, hsa-miR-24-3p and hsa-miR-30c-5p expression were significantly downregulated. While, the Linc00938, LRRK2 and ATP13A2 expression were up-regulated in the PBMC of the PD patients, in comparison to the controls. In addition, this study demonstrated that linc00938 directly sponged hsa-miR-30c-5p. The present study, therefore, for the first time, revealed two candidate lncRNAs as the biomarkers in the PD patients. © 2022, The Author(s).